Patrick R. Sosnay

4.2k total citations · 2 hit papers
37 papers, 1.4k citations indexed

About

Patrick R. Sosnay is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Genetics. According to data from OpenAlex, Patrick R. Sosnay has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 5 papers in Genetics and 3 papers in Genetics. Recurrent topics in Patrick R. Sosnay's work include Cystic Fibrosis Research Advances (31 papers), Neonatal Respiratory Health Research (17 papers) and Tracheal and airway disorders (12 papers). Patrick R. Sosnay is often cited by papers focused on Cystic Fibrosis Research Advances (31 papers), Neonatal Respiratory Health Research (17 papers) and Tracheal and airway disorders (12 papers). Patrick R. Sosnay collaborates with scholars based in United States, United Kingdom and Canada. Patrick R. Sosnay's co-authors include Garry R. Cutting, Philip M. Farrell, Terry B. White, Clement L. Ren, Karen S. Raraigh, Michelle S. Howenstine, Nico Derichs, Margaret Rosenfeld, Isabelle Sermet‐Gaudelus and Susanna A. McColley and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Patrick R. Sosnay

34 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

2017 566 citations Philip M. Farrell, Terry B. White et al. The Journal of Pediatrics profile →
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial

2025 22 citations Bonnie W. Ramsey, Marcus Mall et al. profile →

Peers

Countries citing papers authored by Patrick R. Sosnay

Since Specialization

Citations

This map shows the geographic impact of Patrick R. Sosnay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick R. Sosnay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick R. Sosnay more than expected).

Fields of papers citing papers by Patrick R. Sosnay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick R. Sosnay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick R. Sosnay. The network helps show where Patrick R. Sosnay may publish in the future.

Co-authorship network of co-authors of Patrick R. Sosnay

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick R. Sosnay. A scholar is included among the top collaborators of Patrick R. Sosnay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick R. Sosnay. Patrick R. Sosnay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment 2025 ·Journal of Cystic Fibrosis ·Edith T. Zemanick, Bonnie W. Ramsey, Dorota Sands, Edward F. McKone, Isabelle Fajac, Jennifer L. Taylor‐Cousar, Marcus Mall, Michael W. Konstan, Nitin Nair, Jesse Zhu, Emilio Arteaga‐Solis, Fredrick Van Goor, Lisa J. McGarry, Valentin Prieto-Centurion, Patrick R. Sosnay, Carmen Bozic, David Waltz, Nicole Mayer-Hamblett	6
2	Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis 2024 ·Journal of Patient-Reported Outcomes ·Clara Mukuria, Donna Rowen, Sarah Acaster, Lisa J. McGarry, Yiyue Lou, Patrick R. Sosnay, Alexandra L. Quittner	1
3	PR1 Comparison of the Psychometric Performance of a New Condition-Specific Preference-Based Measure Derived from the Cfq-R (CFQ-R-8D) to EQ-5D-3L and SF-6D to Evaluate Health-Related Quality-of Life (HRQOL) in People with Cystic Fibrosis (CF) 2020 ·Value in Health ·Clara Mukuria, Donna Rowen, John Brazier, Lisa J. McGarry, Alexandra L. Quittner, Yiyue Lou, Patrick R. Sosnay, Sarah Acaster	1
4	Phase 3 efficacy and safety of the ELX/TEZ/IVA triple combination in people with CF homozygous for the F508DEL mutation 2019 ·Ghent University Academic Bibliography (Ghent University) ·Harry Heijerman, (unknown), D.G. Downey, Marcus Mall, Bonnie W. Ramsey, Steven M. Rowe, (unknown), Eva Van Braeckel, John Welter, Neil Ahluwalia, Gautham Marigowda, (unknown), Samuel M. Moskowitz, (unknown), Patrick R. Sosnay, David S. Goldfarb, Fengjuan Xuan, (unknown), Jennifer L. Taylor‐Cousar, Karen McCoy	2
5	Development of the cystic fibrosis questionnaire-revised preference based scoring algorithm 2019 ·Pediatric Pulmonology ·Sarah Acaster, Clara Mukuria, Donna Rowen, John Brazier, Claire Wainwright, Bradley S. Quon, (unknown), Alexandra L. Quittner, Yiyue Lou, Patrick R. Sosnay, Lisa J. McGarry	2
6	Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis 2019 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Karen S. Raraigh, Matthew J. Pellicore, Emily F. Davis-Marcisak, Taylor A. Evans, Sangwoo T. Han, (unknown), Anya T. Joynt, Neeraj Sharma, Carlo Castellani, Joseph M. Collaco, Mary Corey, Michelle Lewis, (unknown), Johanna M. Rommens, Anne L. Stephenson, Patrick R. Sosnay, Garry R. Cutting	66
7	Decreased mRNA and protein stability of W1282X limits response to modulator therapy 2019 ·Journal of Cystic Fibrosis ·Melis A. Aksit, (unknown), Taylor A. Evans, Anya T. Joynt, (unknown), (unknown), Natalie E. West, Christian A. Merlo, Patrick R. Sosnay, Garry R. Cutting, Neeraj Sharma	41
8	Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis 2018 ·PLoS Genetics ·Neeraj Sharma, Taylor A. Evans, Matthew J. Pellicore, Emily F. Davis-Marcisak, Melis A. Aksit, (unknown), Anya T. Joynt, (unknown), Sangwoo T. Han, (unknown), Anh-Thu N. Lam, (unknown), Natalie E. West, Christian A. Merlo, Laura Gottschalk, Karen S. Raraigh, Patrick R. Sosnay, Calvin U. Cotton, Garry R. Cutting	44
9	Sweat test for cystic fibrosis: Wearable sweat sensor vs. standard laboratory test 2018 ·Journal of Cystic Fibrosis ·Dong‐Hoon Choi, (unknown), In Cheol Jeong, (unknown), Patrick R. Sosnay, Garry R. Cutting, Peter C. Searson	60
10	Functional Assays Are Essential for Interpretation of Missense Variants Associated with Variable Expressivity 2018 ·The American Journal of Human Genetics ·Karen S. Raraigh, Sangwoo T. Han, Emily F. Davis-Marcisak, Taylor A. Evans, Matthew J. Pellicore, (unknown), Anya T. Joynt, (unknown), (unknown), Neeraj Sharma, Molly B. Sheridan, Patrick R. Sosnay, Garry R. Cutting	51
11	Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses 2017 ·The Journal of Pediatrics ·Patrick R. Sosnay, Danieli B. Salinas, Terry B. White, Clement L. Ren, Philip M. Farrell, Karen S. Raraigh, (unknown), Carlo Castellani	49
12	Diagnosis of Cystic Fibrosis in Nonscreened Populations 2017 ·The Journal of Pediatrics ·Patrick R. Sosnay, Terry B. White, Philip M. Farrell, Clement L. Ren, Nico Derichs, Michelle S. Howenstine, Jerry A. Nick, K. De Boeck	45
13	Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation 2017 ·Publisher ·Philip M. Farrell, Terry B. White, Clement L. Ren, Sarah E. Hempstead, Frank J. Accurso, Nico Derichs, Michelle S. Howenstine, Susanna A. McColley, Michael J. Rock, Margaret Rosenfeld, Isabelle Sermet‐Gaudelus, Kevin W Southern, Bruce C. Marshall, Patrick R. Sosnay	3
14	Ethnicity impacts the cystic fibrosis diagnosis: A note of caution 2017 ·Journal of Cystic Fibrosis ·Barbara Bosch, Diana Bilton, Patrick R. Sosnay, Karen S. Raraigh, Denise Mak, Hiroshi Ishiguro, Vincent Gulmans, Muriel Thomas, Harry Cuppens, Margarida D. Amaral, K. De Boeck	20
15	Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis 2016 ·American Journal of Respiratory and Critical Care Medicine ·Joseph M. Collaco, Scott M. Blackman, Karen S. Raraigh, Harriet Corvol, Johanna M. Rommens, Rhonda G. Pace, Pierre‐Yves Boëlle, John McGready, Patrick R. Sosnay, Lisa J. Strug, Michael R. Knowles, Garry R. Cutting	58
16	Clinical Phenotypes and Genotypic Spectrum of Cystic Fibrosis in Chinese Children 2016 ·The Journal of Pediatrics ·Yuelin Shen, Jinrong Liu, Li-Li Zhong, Peter J. Mogayzel, Pamela L. Zeitlin, Patrick R. Sosnay, (unknown)	31
17	Molecular Genetics of Cystic Fibrosis Transmembrane Conductance Regulator 2016 ·Pediatric Clinics of North America ·Patrick R. Sosnay, Karen S. Raraigh, Ronald L. Gibson	37
18	Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants 2015 ·Journal of Cystic Fibrosis ·Danieli B. Salinas, Patrick R. Sosnay, Colleen Azen, Suzanne Young, Karen S. Raraigh, Thomas G. Keens, Martin Kharrazi	26
19	Missense variants in CFTR nucleotide-binding domains predict quantitative phenotypes associated with cystic fibrosis disease severity 2014 ·Human Molecular Genetics ·David L. Masica, Patrick R. Sosnay, Karen S. Raraigh, Garry R. Cutting, Rachel Karchin	12
20	Interpretation of genetic variants 2013 ·Thorax ·Patrick R. Sosnay, Garry R. Cutting	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact